These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5262681)

  • 41. Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
    Storti E; Quaglino D
    Recent Results Cancer Res; 1970; 33():344-9. PubMed ID: 5292723
    [No Abstract]   [Full Text] [Related]  

  • 42. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [L-Asparaginase therapy in chemotherapy-resistant acute lymphocytic leukemias (author's transl)].
    Kawashima K; Morishima Y; Kato Y; Suzuki H; Takeyama H; Kobayashi M; Watanabe E; Esaki K; Ogata K; Takamatsu J; Minami S; Yamada K; Naito K; Yoshikawa S; Ogura M; Morishita T; Nishiwaki H; Kawai M; Sako F; Kawabe M; Yamada H
    Rinsho Ketsueki; 1979 Apr; 20(4):355-63. PubMed ID: 286816
    [No Abstract]   [Full Text] [Related]  

  • 44. [L-asparaginase in the treatment of solid tumors and leukemia].
    Heim RR; Freiberg J; Gehrmann G
    Dtsch Med Wochenschr; 1970 May; 95(18):989-93. PubMed ID: 5269095
    [No Abstract]   [Full Text] [Related]  

  • 45. Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
    Gerhartz H; Begemann H
    Recent Results Cancer Res; 1970; 33():244-56. PubMed ID: 5292719
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of the treatment of acute leukemias in children with asparaginase (critical study of 34 cases)].
    Orsini A; Raybaud C; Perrimond H; Sebbah C; Kubasiak M
    Mars Med; 1971; 108(5):341-51. PubMed ID: 5284331
    [No Abstract]   [Full Text] [Related]  

  • 47. [L-asparaginase in the therapy of acute lymphoblastic leukemia in children].
    Massimo L; Fossati-Guglielmoni A; Mori PG; Cottafava F; Costa-del Brenna A; Dagna-Bricarelli F
    Haematologica; 1970; 55(9):603-8. PubMed ID: 4996529
    [No Abstract]   [Full Text] [Related]  

  • 48. [Liver damage after treatment of acute lymphatic leukemia in children].
    Vik T; Moe PJ
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1436-8. PubMed ID: 6579722
    [No Abstract]   [Full Text] [Related]  

  • 49. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I study of ICRF-187 using a daily for 3 days schedule.
    Von Hoff DD; Howser D; Lewis BJ; Holcenberg J; Weiss RB; Young RC
    Cancer Treat Rep; 1981; 65(3-4):249-52. PubMed ID: 6786738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.
    Ramsay NK; Coccia PF; Krivit W; Nesbit ME; Edson JR
    Cancer; 1977 Oct; 40(4):1398-401. PubMed ID: 269003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preliminary studies on the treatment of acute lymphocytic leukemia of the child with L-asparaginase].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtoni E; Bruschelli M; Astaldi AA
    Haematol Lat; 1968; 11(4):311-47. PubMed ID: 4899936
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunization against L-asparaginase. Demonstration and characteristics of antibodies. Clinical value].
    Marsalet YD; Lambert G; Hornez JP; Bauters F; Goudemand M
    Nouv Presse Med; 1973 Jun; 2(23):1575-8. PubMed ID: 4197351
    [No Abstract]   [Full Text] [Related]  

  • 56. L-Asparaginase-induced coagulopathy during therapy of acute lymphocytic leukemia.
    Sills RH; Nelson DA; Stockman JA
    Med Pediatr Oncol; 1978; 4(4):311-3. PubMed ID: 281595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Results of L-asparaginase therapy in acute leukemia of the adult].
    Pannacciulli I
    Haematologica; 1970; 55(9):597-602. PubMed ID: 4996528
    [No Abstract]   [Full Text] [Related]  

  • 58. [Transient diabetes mellitus during L-asparaginase therapy].
    Zoltán K; István V
    Orv Hetil; 1975 Jul; 116(28):1644-5. PubMed ID: 1056586
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diabetic ketoacidosis and hypofibrinogenemia as a complication of the treatment with L-asparaginase of acute lymphoblastic leukemia].
    López Herce Cid J; Martínez A; González M; García S
    Sangre (Barc); 1986; 31(2):195-9. PubMed ID: 3088740
    [No Abstract]   [Full Text] [Related]  

  • 60. [L-asparaginase in the treatment of acute leukoses].
    Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
    Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.